ПРЕПРИНТ
О результатах, изложенных в препринтах, не следует сообщать в СМИ как о проверенной информации.
The global incidence of early-onset cancer, diagnosed before age 50, is rising, with pronounced birth cohort effects. This alarming trend underscores an urgent need to accelerate discovery of novel cancer risk factors and their underlying biological networks, and to translate these insights into prevention and interception strategies that protect future generations. In this Perspective, we summarize key milestones and outline conceptual, methodological, and resource-related challenges that are hindering progress. To address these gaps, we propose three interconnected frameworks that extend traditional epidemiologic approaches: (1) a tissue-ecosystem anchored, critical window-aware framework for cancer risk factor discovery; (2) a life course informed, biological state-based framework for precision cancer risk assessment; and (3) an integrated, dynamic, natural history-based framework to characterize cancer preventability. Together, they offer an initial roadmap for connecting exposures to molecular changes across biological scales, life stages, and populations to reveal the networks of causal risk factors. By beginning to map when and where risk factors disrupt shared hallmarks of cancer, reflected in shifts in (epi)genetic, immune, metabolic, and microbial pathways, these approaches can start to inform biologically grounded, scalable strategies to prevent cancer and other chronic diseases.
Sarsenova A. D. 2026. Accelerating Cancer Risk Factor Discovery for Prevention in Younger Generations. PREPRINTS.RU. https://doi.org/10.24108/preprints-3114438
1. Siegel, R.L., Giaquinto, A.N., and Jemal, A. (2024). Cancer statistics, 2024. CA Cancer J Clin 74, 12-49. 10.3322/caac.21820.
2. Sung, H., Siegel, R.L., Laversanne, M., Jiang, C., Morgan, E., Zahwe, M., Cao, Y., Bray, F., and Jemal, A. (2025). Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. Lancet Oncol 26, 51-63. 10.1016/s1470-2045(24)00600-4.
3. Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., and Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74, 229-263. 10.3322/caac.21834.
4. Jianhui, Z., Liying, X., Jing, S., Mingyang, S., Lijuan, W., Shuai, Y., Yingshuang, Z., Zhengwei, W., Susanna, L., Konstantinos, T., et al. (2023). Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncology 2, e000049. 10.1136/bmjonc-2023-000049.
5. Berrington de Gonzalez, A., Brayley, M., Frost, R., Freedman, N., Gunter, M.J., Jackson, I., Lapitan, P., Shiels, M.S., and García-Closas, M. (2025). Trends in Cancer Incidence in Younger and Older Adults : An International Comparative Analysis. Ann Intern Med. 10.7326/annals-24-02718.
6. Yan, W., Liu, M., Jing, W., Kang, L., Zhang, N., Sun, H., He, J., Chen, Z., Liu, J., Liang, W., and Dong, J. (2025). Disparities in the incidence, mortality and disability-adjusted life years of 33 early-onset cancer groups globally, 2012-2021: a systematic analysis. Exp Hematol Oncol 14, 38. 10.1186/s40164-025-00634-7.
7. Shiels, M.S., Haque, A.T., Berrington de González, A., Camargo, M.C., Clarke, M.A., Davis Lynn, B.C., Engels, E.A., Freedman, N.D., Gierach, G.L., Hofmann, J.N., et al. (2025). Trends in Cancer Incidence and Mortality Rates in Early-Onset and Older-Onset Age Groups in the United States, 2010-2019. Cancer Discov 15, 1363-1376. 10.1158/2159-8290.Cd-24-1678.
8. Sung, H., Jiang, C., Bandi, P., Minihan, A., Fidler-Benaoudia, M., Islami, F., Siegel, R.L., and Jemal, A. (2024). Differences in cancer rates among adults born between 1920 and 1990 in the USA: an analysis of population-based cancer registry data. Lancet Public Health 9, e583-e593. 10.1016/s2468-2667(24)00156-7.
9. Sung, H., Siegel, R.L., Rosenberg, P.S., and Jemal, A. (2019). Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health 4, e137-e147. 10.1016/s2468-2667(18)30267-6.
10. Rosenberg, P.S., and Miranda-Filho, A. (2024). Cancer Incidence Trends in Successive Social Generations in the US. JAMA Netw Open 7, e2415731. 10.1001/jamanetworkopen.2024.15731.
11. Doll, R., and Peto, R. (1981). The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. JNCI: Journal of the National Cancer Institute 66, 1192-1308.
12. Jha, P. (2009). Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer 9, 655-664. 10.1038/nrc2703.
13. Jha, P., and Peto, R. (2014). Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med 370, 60-68. 10.1056/NEJMra1308383.
14. Islami, F., Marlow, E.C., Thomson, B., McCullough, M.L., Rumgay, H., Gapstur, S.M., Patel, A.V., Soerjomataram, I., and Jemal, A. (2024). Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019. CA Cancer J Clin 74, 405-432. 10.3322/caac.21858.
15. Brennan, P., and Davey-Smith, G. (2022). Identifying Novel Causes of Cancers to Enhance Cancer Prevention: New Strategies Are Needed. J Natl Cancer Inst 114, 353-360. 10.1093/jnci/djab204.
16. Cao, Y., Nguyen, L.H., Tica, S., Otegbeye, E., Zong, X., Roelstraete, B., Chan, A.T., Warner, B.B., Stephansson, O., and Ludvigsson, J.F. (2023). Evaluation of Birth by Cesarean Delivery and Development of Early-Onset Colorectal Cancer. JAMA Netw Open 6, e2310316. 10.1001/jamanetworkopen.2023.10316.
17. Peeri, N.C., O'Connell, K., Kantor, E.D., Setiawan, V.W., Guo, X., Lipworth, L., and Du, M. (2024). Early-Life Factors and Early-Onset Endometrial Cancer Risk in the UK Biobank. JAMA Netw Open 7, e2440181. 10.1001/jamanetworkopen.2024.40181.
18. Wang, C., Du, M., Kim, H., Nguyen, L.H., Wang, Q.L., Drew, D.A., Leeming, E.R., Khandpur, N., Sun, Q., Zong, X., et al. (2025). Ultraprocessed Food Consumption and Risk of Early-Onset Colorectal Cancer Precursors Among Women. JAMA Oncol. 10.1001/jamaoncol.2025.4777.
19. Fortin, B.M., Mahieu, A.L., Fellows, R.C., Kang, Y., Lewis, A.N., Ead, A.S., Lamia, K.A., Cao, Y., Pannunzio, N.R., and Masri, S. (2025). The diverse roles of the circadian clock in cancer. Nat Cancer 6, 753-767. 10.1038/s43018-025-00981-8.
20. Patel, C.J. (2017). Analytic Complexity and Challenges in Identifying Mixtures of Exposures Associated with Phenotypes in the Exposome Era. Curr Epidemiol Rep 4, 22-30. 10.1007/s40471-017-0100-5.
21. Wang, Z., Walker, G.W., Muir, D.C.G., and Nagatani-Yoshida, K. (2020). Toward a Global Understanding of Chemical Pollution: A First Comprehensive Analysis of National and Regional Chemical Inventories. Environ Sci Technol 54, 2575-2584. 10.1021/acs.est.9b06379.
22. Parrish, M., and Kuperwasser, C. (2025). Environmental endocrine disruptors: rethinking the origins of early-onset ER(+) breast cancer. Nat Rev Cancer 25, 819-820. 10.1038/s41568-025-00854-3.
23. Orešič, M., Karu, N., Zhao, H.N., Moseley, A., Hankemeier, T., Wishart, D.S., Dorrestein, P.C., Fiehn, O., Hyötyläinen, T., and Daouk, R.K. (2025). Metabolome informs about the chemical exposome and links to brain health. Environ Int 203, 109741. 10.1016/j.envint.2025.109741.
24. Wild, C.P. (2005). Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 14, 1847-1850. 10.1158/1055-9965.Epi-05-0456.
25. Balmain, A. (2023). Peto's paradox revisited: black box vs mechanistic approaches to understanding the roles of mutations and promoting factors in cancer. Eur J Epidemiol 38, 1251-1258. 10.1007/s10654-022-00933-x.
26. Jassim, A., Rahrmann, E.P., Simons, B.D., and Gilbertson, R.J. (2023). Cancers make their own luck: theories of cancer origins. Nat Rev Cancer 23, 710-724. 10.1038/s41568-023-00602-5.
27. Rozhok, A.I., and DeGregori, J. (2017). Chapter 12 - Aging, Somatic Evolution, and Cancer. In On Human Nature, M. Tibayrenc, and F.J. Ayala, eds. (Academic Press), pp. 193-209. https://doi.org/10.1016/B978-0-12-420190-3.00012-0.
28. Weeden, C.E., Hill, W., Lim, E.L., Grönroos, E., and Swanton, C. (2023). Impact of risk factors on early cancer evolution. Cell 186, 1541-1563. 10.1016/j.cell.2023.03.013.
29. Samet, J.M., Chiu, W.A., Cogliano, V., Jinot, J., Kriebel, D., Lunn, R.M., Beland, F.A., Bero, L., Browne, P., Fritschi, L., et al. (2020). The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification. J Natl Cancer Inst 112, 30-37. 10.1093/jnci/djz169.
30. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. (2022). Lancet 400, 563-591. 10.1016/s0140-6736(22)01438-6.
31. Hill, J. (1761). Cautions against the immoderate use of snuff. Founded on the known qualities of the tobacco plant; and the effects it must produce when this way taken into the body (R. Baldwin; J. Jackson).
32. Redmond, D.E., Jr. (1970). Tobacco and cancer: the first clinical report, 1761. N Engl J Med 282, 18-23. 10.1056/nejm197001012820105.
33. Soemmerring, S.T. (1795). De Morbis Vasorum Absorbentium Corporis Humani Sive Dissertationis Quae Praemium Retulit Societatis Rheno-Traiectinae Anno MDCCLXXXXIV. Pars...; Accedit Index Scriptorum De Systemate Absorbente (Varrentrappius & Wenner).
34. Wynder, E.L., and Graham, E.A. (1950). Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J Am Med Assoc 143, 329-336. 10.1001/jama.1950.02910390001001.
35. Doll, R., and Hill, A.B. (1952). A study of the aetiology of carcinoma of the lung. Br Med J 2, 1271-1286. 10.1136/bmj.2.4797.1271.
36. Doll, R., and Peto, R. (1976). Mortality in relation to smoking: 20 years' observations on male British doctors. Br med J 2, 1525-1536.
37. Service, U.P.H. (1964). Surgeon General's advisory committee on smoking and health. Washington, DC: US Government Printing Office.
38. Wynder, E.L., Graham, E.A., and Croninger, A.B. (1953). Experimental production of carcinoma with cigarette tar. Cancer Res 13, 855-864.
39. Hecht, S.S. (2003). Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3, 733-744. 10.1038/nrc1190.
40. Denissenko, M.F., Pao, A., Tang, M.-s., and Pfeifer, G.P. (1996). Preferential formation of benzo [a] pyrene adducts at lung cancer mutational hotspots in P53. Science 274, 430-432.
41. Rodenhuis, S., van de Wetering, M.L., Mooi, W.J., Evers, S.G., van Zandwijk, N., and Bos, J.L. (1987). Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med 317, 929-935. 10.1056/nejm198710083171504.
42. Alexandrov, L.B., Ju, Y.S., Haase, K., Van Loo, P., Martincorena, I., Nik-Zainal, S., Totoki, Y., Fujimoto, A., Nakagawa, H., Shibata, T., et al. (2016). Mutational signatures associated with tobacco smoking in human cancer. Science 354, 618-622. 10.1126/science.aag0299.
43. Lamu, L. (1910). Etude de statistique clinique de 131 cas de cancer de l’oesophage et du cardia. Arch Mal Appar Dig Mal Nutr 4, 451-456.
44. Wynder, E.L., Lemon, F.R., and Bross, I.J. (1959). Cancer and coronary artery disease among Seventh-Day Adventists. Cancer 12, 1016-1028. 10.1002/1097-0142(195909/10)12:5<1016::aid-cncr2820120523>3.0.co;2-2.
45. Lemon, F.R., Walden, R.T., and Woods, R.W. (1964). CANCER OF THE LUNG AND MOUTH IN SEVENTH-DAY ADVENTISTS. PRELIMINARY REPORT ON A POPULATION STUDY. Cancer 17, 486-497. 10.1002/1097-0142(196404)17:4<486::aid-cncr2820170410>3.0.co;2-z.
46. Phillips, R.L., Garfinkel, L., Kuzma, J.W., Beeson, W.L., Lotz, T., and Brin, B. (1980). Mortality among California Seventh-Day Adventists for selected cancer sites. J Natl Cancer Inst 65, 1097-1107.
47. Alcohol drinking. (1988). IARC Monogr Eval Carcinog Risks Hum 44, 1-378.
48. Bagnardi, V., Rota, M., Botteri, E., Tramacere, I., Islami, F., Fedirko, V., Scotti, L., Jenab, M., Turati, F., Pasquali, E., et al. (2015). Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer 112, 580-593. 10.1038/bjc.2014.579.
49. Giovannucci, E., Stampfer, M.J., Colditz, G.A., Rimm, E.B., Trichopoulos, D., Rosner, B.A., Speizer, F.E., and Willett, W.C. (1993). Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 85, 875-884. 10.1093/jnci/85.11.875.
50. Ferrari, P., Jenab, M., Norat, T., Moskal, A., Slimani, N., Olsen, A., Tjønneland, A., Overvad, K., Jensen, M.K., Boutron-Ruault, M.C., et al. (2007). Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 121, 2065-2072. 10.1002/ijc.22966.
51. Smith-Warner, S.A., Spiegelman, D., Yaun, S.S., van den Brandt, P.A., Folsom, A.R., Goldbohm, R.A., Graham, S., Holmberg, L., Howe, G.R., Marshall, J.R., et al. (1998). Alcohol and breast cancer in women: a pooled analysis of cohort studies. Jama 279, 535-540. 10.1001/jama.279.7.535.
52. Graham, S. (1987). Alcohol and Breast Cancer. New England Journal of Medicine 316, 1211-1213. doi:10.1056/NEJM198705073161908.
53. Hamajima, N., Hirose, K., Tajima, K., Rohan, T., Calle, E.E., Heath, C.W., Jr., Coates, R.J., Liff, J.M., Talamini, R., Chantarakul, N., et al. (2002). Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 87, 1234-1245. 10.1038/sj.bjc.6600596.
54. Alcohol consumption and ethyl carbamate. (2010). IARC Monogr Eval Carcinog Risks Hum 96, 3-1383.
55. Pöschl, G., and Seitz, H.K. (2004). ALCOHOL AND CANCER. Alcohol and Alcoholism 39, 155-165. 10.1093/alcalc/agh057.
56. Druesne-Pecollo, N., Tehard, B., Mallet, Y., Gerber, M., Norat, T., Hercberg, S., and Latino-Martel, P. (2009). Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol 10, 173-180. 10.1016/s1470-2045(09)70019-1.
57. Rumgay, H., Murphy, N., Ferrari, P., and Soerjomataram, I. (2021). Alcohol and Cancer: Epidemiology and Biological Mechanisms. Nutrients 13. 10.3390/nu13093173.
58. Hashibe, M., Brennan, P., Chuang, S.C., Boccia, S., Castellsague, X., Chen, C., Curado, M.P., Dal Maso, L., Daudt, A.W., Fabianova, E., et al. (2009). Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 18, 541-550. 10.1158/1055-9965.Epi-08-0347.
59. Zeka, A., Gore, R., and Kriebel, D. (2003). Effects of alcohol and tobacco on aerodigestive cancer risks: a meta-regression analysis. Cancer Causes Control 14, 897-906. 10.1023/b:caco.0000003854.34221.a8.
60. Services, U.S.D.o.A.a.U.S.D.o.H.a.H. (December 2020). Dietary Guidelines for Americans, 2020-2025. . https://www.dietaryguidelines.gov/.
61. Office of the Surgeon, G. (2025). Publications and Reports of the Surgeon General. In Alcohol and Cancer Risk: The U.S. Surgeon General’s Advisory, (US Department of Health and Human Services).
62. Flegal, K.M., Carroll, M.D., Kuczmarski, R.J., and Johnson, C.L. (1998). Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22, 39-47. 10.1038/sj.ijo.0800541.
63. Kuczmarski, R.J., Flegal, K.M., Campbell, S.M., and Johnson, C.L. (1994). Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. Jama 272, 205-211. 10.1001/jama.272.3.205.
64. Lew, E.A., and Garfinkel, L. (1979). Variations in mortality by weight among 750,000 men and women. J Chronic Dis 32, 563-576. 10.1016/0021-9681(79)90119-x.
65. Calle, E.E., Rodriguez, C., Walker-Thurmond, K., and Thun, M.J. (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348, 1625-1638. 10.1056/NEJMoa021423.
66. Whitlock, G., Lewington, S., Sherliker, P., Clarke, R., Emberson, J., Halsey, J., Qizilbash, N., Collins, R., and Peto, R. (2009). Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373, 1083-1096. 10.1016/s0140-6736(09)60318-4.
67. Cancer, I.A.f.R.o. (2002). Weight control and physical activity. In Weight control and physical activity.
68. Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., and Straif, K. (2016). Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med 375, 794-798. 10.1056/NEJMsr1606602.
69. Hopkins, B.D., Goncalves, M.D., and Cantley, L.C. (2016). Obesity and Cancer Mechanisms: Cancer Metabolism. J Clin Oncol 34, 4277-4283. 10.1200/jco.2016.67.9712.
70. Avgerinos, K.I., Spyrou, N., Mantzoros, C.S., and Dalamaga, M. (2019). Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism 92, 121-135. 10.1016/j.metabol.2018.11.001.
71. Rakib, A., Mamun, M.A.A., Mandal, M., Sinha, P., and Singh, U.P. (2025). Obesity-cancer axis crosstalk: Molecular insights and therapeutic approaches. Acta Pharm Sin B 15, 2930-2944. 10.1016/j.apsb.2025.04.029.
72. Du, M., Drew, D.A., Goncalves, M.D., Cao, Y., and Chan, A.T. (2025). Early-onset colorectal cancer as an emerging disease of metabolic dysregulation. Nat Rev Endocrinol 21, 686-702. 10.1038/s41574-025-01159-z.
73. Qing, T., Mohsen, H., Marczyk, M., Ye, Y., O'Meara, T., Zhao, H., Townsend, J.P., Gerstein, M., Hatzis, C., Kluger, Y., and Pusztai, L. (2020). Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden. Nat Commun 11, 2438. 10.1038/s41467-020-16293-7.
74. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L.M., Ding, W., and et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71. 10.1126/science.7545954.
75. Wooster, R., Neuhausen, S.L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., and et al. (1994). Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265, 2088-2090. 10.1126/science.8091231.
76. Hall, J.M., Lee, M.K., Newman, B., Morrow, J.E., Anderson, L.A., Huey, B., and King, M.C. (1990). Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684-1689. 10.1126/science.2270482.
77. Peltomäki, P., Aaltonen, L.A., Sistonen, P., Pylkkänen, L., Mecklin, J.P., Järvinen, H., Green, J.S., Jass, J.R., Weber, J.L., Leach, F.S., and et al. (1993). Genetic mapping of a locus predisposing to human colorectal cancer. Science 260, 810-812. 10.1126/science.8484120.
78. Lindblom, A., Tannergård, P., Werelius, B., and Nordenskjöld, M. (1993). Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 5, 279-282. 10.1038/ng1193-279.
79. Kinzler, K.W., Nilbert, M.C., Su, L.K., Vogelstein, B., Bryan, T.M., Levy, D.B., Smith, K.J., Preisinger, A.C., Hedge, P., McKechnie, D., and et al. (1991). Identification of FAP locus genes from chromosome 5q21. Science 253, 661-665. 10.1126/science.1651562.
80. Fishel, R., Lescoe, M.K., Rao, M.R., Copeland, N.G., Jenkins, N.A., Garber, J., Kane, M., and Kolodner, R. (1993). The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75, 1027-1038. 10.1016/0092-8674(93)90546-3.
81. Sud, A., Kinnersley, B., and Houlston, R.S. (2017). Genome-wide association studies of cancer: current insights and future perspectives. Nat Rev Cancer 17, 692-704. 10.1038/nrc.2017.82.
82. Zhang, H., Ahearn, T.U., Lecarpentier, J., Barnes, D., Beesley, J., Qi, G., Jiang, X., O'Mara, T.A., Zhao, N., Bolla, M.K., et al. (2020). Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genet 52, 572-581. 10.1038/s41588-020-0609-2.
83. Fernandez-Rozadilla, C., Timofeeva, M., Chen, Z., Law, P., Thomas, M., Schmit, S., Díez-Obrero, V., Hsu, L., Fernandez-Tajes, J., Palles, C., et al. (2023). Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. Nat Genet 55, 89-99. 10.1038/s41588-022-01222-9.
84. Law, P.J., Studd, J., Smith, J., Vijayakrishnan, J., Harris, B.T., Mandelia, M., Mills, C., Dunlop, M.G., and Houlston, R.S. (2024). Systematic prioritization of functional variants and effector genes underlying colorectal cancer risk. Nat Genet 56, 2104-2111. 10.1038/s41588-024-01900-w.
85. Bossé, Y., and Amos, C.I. (2018). A Decade of GWAS Results in Lung Cancer. Cancer Epidemiol Biomarkers Prev 27, 363-379. 10.1158/1055-9965.Epi-16-0794.
86. Gorman, B.R., Ji, S.G., Francis, M., Sendamarai, A.K., Shi, Y., Devineni, P., Saxena, U., Partan, E., DeVito, A.K., Byun, J., et al. (2024). Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk. Nat Commun 15, 8629. 10.1038/s41467-024-52129-4.
87. Qian, D.C., Byun, J., Han, Y., Greene, C.S., Field, J.K., Hung, R.J., Brhane, Y., McLaughlin, J.R., Fehringer, G., Landi, M.T., et al. (2015). Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions. Hum Mol Genet 24, 7406-7420. 10.1093/hmg/ddv440.
88. Kuenzi, B.M., and Ideker, T. (2020). A census of pathway maps in cancer systems biology. Nat Rev Cancer 20, 233-246. 10.1038/s41568-020-0240-7.
89. Huntley, C., Torr, B., Sud, A., Rowlands, C.F., Way, R., Snape, K., Hanson, H., Swanton, C., Broggio, J., Lucassen, A., et al. (2023). Utility of polygenic risk scores in UK cancer screening: a modelling analysis. Lancet Oncol 24, 658-668. 10.1016/s1470-2045(23)00156-0.
90. Mavaddat, N., Michailidou, K., Dennis, J., Lush, M., Fachal, L., Lee, A., Tyrer, J.P., Chen, T.H., Wang, Q., Bolla, M.K., et al. (2019). Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet 104, 21-34. 10.1016/j.ajhg.2018.11.002.
91. Thomas, M., Sakoda, L.C., Hoffmeister, M., Rosenthal, E.A., Lee, J.K., van Duijnhoven, F.J.B., Platz, E.A., Wu, A.H., Dampier, C.H., de la Chapelle, A., et al. (2020). Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk. Am J Hum Genet 107, 432-444. 10.1016/j.ajhg.2020.07.006.
92. Peto, R. (2023). The need for Ignorance in cancer research. Eur J Epidemiol 38, 1239-1243. 10.1007/s10654-023-01085-2.
93. Islami, F., Nargis, N., Liu, Q., Bandi, P., Siegel, R.L., Choudhury, P.P., Freedman, N.D., Warner, K.E., and Jemal, A. (2025). Averted lung cancer deaths due to reductions in cigarette smoking in the United States, 1970-2022. CA Cancer J Clin 75, 216-225. 10.3322/caac.70005.
94. Swinburn, B.A., Kraak, V.I., Allender, S., Atkins, V.J., Baker, P.I., Bogard, J.R., Brinsden, H., Calvillo, A., De Schutter, O., Devarajan, R., et al. (2019). The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report. Lancet 393, 791-846. 10.1016/s0140-6736(18)32822-8.
95. Dai, H., Li, Y., Lee, Y.A., Lu, Y., George, T.J., Donahoo, W.T., Lee, K.P., Nakshatri, H., Allen, J., Guo, Y., et al. (2025). GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity. JAMA Oncol 11, 1186-1193. 10.1001/jamaoncol.2025.2681.
96. Armitage, P., and Doll, R. (1954). The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 8, 1-12. 10.1038/bjc.1954.1.
97. Mahabir, S., Aagaard, K., Anderson, L.M., Herceg, Z., Hiatt, R.A., Hoover, R.N., Linet, M.S., Medina, D., Potischman, N., Tretli, S., et al. (2012). Challenges and opportunities in research on early-life events/exposures and cancer development later in life. Cancer Causes Control 23, 983-990. 10.1007/s10552-012-9962-5.
98. Calabrese, E.J. (2021). Ethical failings: The problematic history of cancer risk assessment. Environ Res 193, 110582. 10.1016/j.envres.2020.110582.
99. Akhtar, A. (2015). The flaws and human harms of animal experimentation. Camb Q Healthc Ethics 24, 407-419. 10.1017/s0963180115000079.
100. Cheluvappa, R., Scowen, P., and Eri, R. (2017). Ethics of animal research in human disease remediation, its institutional teaching; and alternatives to animal experimentation. Pharmacol Res Perspect 5. 10.1002/prp2.332.
101. Patiño-García, A., Guruceaga, E., Andueza, M.P., Ocón, M., Fodop Sokoudjou, J.J., de Villalonga Zornoza, N., Alkorta-Aranburu, G., Uria, I.T., Gurpide, A., Camps, C., et al. (2024). Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma. EBioMedicine 102, 105048. 10.1016/j.ebiom.2024.105048.
102. Foulkes, W.D., Knoppers, B.M., and Turnbull, C. (2016). Population genetic testing for cancer susceptibility: founder mutations to genomes. Nat Rev Clin Oncol 13, 41-54. 10.1038/nrclinonc.2015.173.
103. Greaves, M. (2015). Evolutionary determinants of cancer. Cancer Discov 5, 806-820. 10.1158/2159-8290.Cd-15-0439.
104. Alfaro-Murillo, J.A., and Townsend, J.P. (2023). Pairwise and higher-order epistatic effects among somatic cancer mutations across oncogenesis. Math Biosci 366, 109091. 10.1016/j.mbs.2023.109091.
105. McGranahan, N., and Swanton, C. (2017). Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell 168, 613-628. 10.1016/j.cell.2017.01.018.
106. Hunter, D.J. (2005). Gene-environment interactions in human diseases. Nat Rev Genet 6, 287-298. 10.1038/nrg1578.
107. Hutter, C.M., Mechanic, L.E., Chatterjee, N., Kraft, P., and Gillanders, E.M. (2013). Gene-environment interactions in cancer epidemiology: a National Cancer Institute Think Tank report. Genet Epidemiol 37, 643-657. 10.1002/gepi.21756.
108. Ahsan, H., Halpern, J., Kibriya, M.G., Pierce, B.L., Tong, L., Gamazon, E., McGuire, V., Felberg, A., Shi, J., Jasmine, F., et al. (2014). A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. Cancer Epidemiol Biomarkers Prev 23, 658-669. 10.1158/1055-9965.Epi-13-0340.
109. Laskar, R.S., Qu, C., Huyghe, J.R., Harrison, T., Hayes, R.B., Cao, Y., Campbell, P.T., Steinfelder, R., Talukdar, F.R., Brenner, H., et al. (2024). Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer. Ann Oncol 35, 523-536. 10.1016/j.annonc.2024.02.008.
110. Siegel, R.L., Fedewa, S.A., Anderson, W.F., Miller, K.D., Ma, J., Rosenberg, P.S., and Jemal, A. (2017). Colorectal Cancer Incidence Patterns in the United States, 1974-2013. J Natl Cancer Inst 109. 10.1093/jnci/djw322.
111. Chen, J., and Yang, W. (2024). Comparing cohort and period trends of early-onset colorectal cancer: a global analysis. JNCI Cancer Spectr 8. 10.1093/jncics/pkae052.
112. Holford, T.R. (1983). The estimation of age, period and cohort effects for vital rates. Biometrics 39, 311-324.
113. Liu, Y., Colditz, G.A., Rosner, B., Berkey, C.S., Collins, L.C., Schnitt, S.J., Connolly, J.L., Chen, W.Y., Willett, W.C., and Tamimi, R.M. (2013). Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst 105, 1571-1578. 10.1093/jnci/djt213.
114. White, A.J., DeRoo, L.A., Weinberg, C.R., and Sandler, D.P. (2017). Lifetime Alcohol Intake, Binge Drinking Behaviors, and Breast Cancer Risk. Am J Epidemiol 186, 541-549. 10.1093/aje/kwx118.
115. Lupi, M., Martinotti, G., and Di Giannantonio, M. (2017). Drunkorexia: an emerging trend in young adults. Eat Weight Disord 22, 619-622. 10.1007/s40519-017-0429-2.
116. Wild, C.P. (2012). The exposome: from concept to utility. Int J Epidemiol 41, 24-32. 10.1093/ije/dyr236.
117. Jones, D.P. (2016). Sequencing the exposome: A call to action. Toxicol Rep 3, 29-45. 10.1016/j.toxrep.2015.11.009.
118. Stancliffe, E., Schwaiger-Haber, M., Sindelar, M., Murphy, M.J., Soerensen, M., and Patti, G.J. (2022). An Untargeted Metabolomics Workflow that Scales to Thousands of Samples for Population-Based Studies. Anal Chem 94, 17370-17378. 10.1021/acs.analchem.2c01270.
119. Swanton, C., Bernard, E., Abbosh, C., André, F., Auwerx, J., Balmain, A., Bar-Sagi, D., Bernards, R., Bullman, S., DeGregori, J., et al. (2024). Embracing cancer complexity: Hallmarks of systemic disease. Cell 187, 1589-1616. 10.1016/j.cell.2024.02.009.
120. Cannataro, V.L., Mandell, J.D., and Townsend, J.P. (2022). Attribution of Cancer Origins to Endogenous, Exogenous, and Preventable Mutational Processes. Mol Biol Evol 39. 10.1093/molbev/msac084.
121. Gapstur, S.M., Bouvard, V., Nethan, S.T., Freudenheim, J.L., Abnet, C.C., English, D.R., Rehm, J., Balbo, S., Buykx, P., Crabb, D., et al. (2023). The IARC Perspective on Alcohol Reduction or Cessation and Cancer Risk. N Engl J Med 389, 2486-2494. 10.1056/NEJMsr2306723.
122. National Center for Chronic Disease, P., Health Promotion Office on, S., and Health (2014). Reports of the Surgeon General. In The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General, (Centers for Disease Control and Prevention (US)).
123. Goldmann, J.M., Veltman, J.A., and Gilissen, C. (2019). De Novo Mutations Reflect Development and Aging of the Human Germline. Trends Genet 35, 828-839. 10.1016/j.tig.2019.08.005.
124. Kim, H.S., Xiao, X., Byun, J., Jun, G., DeSantis, S.M., Chen, H., Thrift, A.P., El-Serag, H.B., Kanwal, F., and Amos, C.I. (2022). Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality. JAMA Netw Open 5, e2234221. 10.1001/jamanetworkopen.2022.34221.
125. Zhang, Y., Lindström, S., Kraft, P., and Liu, Y. (2025). Genetic risk, health-associated lifestyle, and risk of early-onset total cancer and breast cancer. J Natl Cancer Inst 117, 40-48. 10.1093/jnci/djae208.
126. Zhou, R., Tang, X., and Wang, Y. (2024). Emerging strategies to investigate the biology of early cancer. Nat Rev Cancer 24, 850-866. 10.1038/s41568-024-00754-y.
127. Fraser, A., Macdonald-Wallis, C., Tilling, K., Boyd, A., Golding, J., Davey Smith, G., Henderson, J., Macleod, J., Molloy, L., Ness, A., et al. (2013). Cohort Profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol 42, 97-110. 10.1093/ije/dys066.
128. Olsen, J., Melbye, M., Olsen, S.F., Sørensen, T.I., Aaby, P., Andersen, A.M., Taxbøl, D., Hansen, K.D., Juhl, M., Schow, T.B., et al. (2001). The Danish National Birth Cohort--its background, structure and aim. Scand J Public Health 29, 300-307. 10.1177/14034948010290040201.
129. Scholtens, S., Smidt, N., Swertz, M.A., Bakker, S.J., Dotinga, A., Vonk, J.M., van Dijk, F., van Zon, S.K., Wijmenga, C., Wolffenbuttel, B.H., and Stolk, R.P. (2015). Cohort Profile: LifeLines, a three-generation cohort study and biobank. Int J Epidemiol 44, 1172-1180. 10.1093/ije/dyu229.
130. Hofman, A., Jaddoe, V.W., Mackenbach, J.P., Moll, H.A., Snijders, R.F., Steegers, E.A., Verhulst, F.C., Witteman, J.C., and Büller, H.A. (2004). Growth, development and health from early fetal life until young adulthood: the Generation R Study. Paediatr Perinat Epidemiol 18, 61-72. 10.1111/j.1365-3016.2003.00521.x.
131. Cancer, I.A.f.R.o. DISCERN: Discovering the Causes of Three Poorly Understood Cancers in Europe. https://discern.iarc.who.int/.
132. Jiang, S., and Colditz, G.A. (2023). Causal mediation analysis using high-dimensional image mediator bounded in irregular domain with an application to breast cancer. Biometrics 79, 3728-3738. 10.1111/biom.13847.
133. Wagner, C., Carmeli, C., Jackisch, J., Kivimäki, M., van der Linden, B.W.A., Cullati, S., and Chiolero, A. (2024). Life course epidemiology and public health. Lancet Public Health 9, e261-e269. 10.1016/s2468-2667(24)00018-5.
134. Richardson, T.G., Urquijo, H., Holmes, M.V., and Davey Smith, G. (2023). Leveraging family history data to disentangle time-varying effects on disease risk using lifecourse mendelian randomization. Eur J Epidemiol 38, 765-769. 10.1007/s10654-023-01001-8.
135. Naimi, A.I., Cole, S.R., and Kennedy, E.H. (2017). An introduction to g methods. Int J Epidemiol 46, 756-762. 10.1093/ije/dyw323.
136. De Stavola, B.L., and Daniel, R.M. (2017). Commentary: Incorporating concepts and methods from causal inference into life course epidemiology. Int J Epidemiol 46, 771. 10.1093/ije/dyw367.
137. Hernán, M.A., Wang, W., and Leaf, D.E. (2022). Target Trial Emulation: A Framework for Causal Inference From Observational Data. Jama 328, 2446-2447. 10.1001/jama.2022.21383.
138. Campbell, P.J. (2023). Demystifying the black box: from ignorance to observation to mechanism in cancer research. Eur J Epidemiol 38, 1265-1267. 10.1007/s10654-022-00935-9.
139. Plutynski, A. (2023). On Explaining Peto's Paradox. Eur J Epidemiol 38, 1245-1250. 10.1007/s10654-022-00920-2.
140. Davey Smith, G., Hofman, A., and Brennan, P. (2023). Chance, ignorance, and the paradoxes of cancer: Richard Peto on developing preventative strategies under uncertainty. Eur J Epidemiol 38, 1227-1237. 10.1007/s10654-023-01090-5.
141. Boddy, A.M. (2023). The need for evolutionary theory in cancer research. Eur J Epidemiol 38, 1259-1264. 10.1007/s10654-022-00936-8.
142. Yizhak, K., Aguet, F., Kim, J., Hess, J.M., Kübler, K., Grimsby, J., Frazer, R., Zhang, H., Haradhvala, N.J., Rosebrock, D., et al. (2019). RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues. Science 364. 10.1126/science.aaw0726.
143. Lee-Six, H., Olafsson, S., Ellis, P., Osborne, R.J., Sanders, M.A., Moore, L., Georgakopoulos, N., Torrente, F., Noorani, A., Goddard, M., et al. (2019). The landscape of somatic mutation in normal colorectal epithelial cells. Nature 574, 532-537. 10.1038/s41586-019-1672-7.
144. Hill, W., Lim, E.L., Weeden, C.E., Lee, C., Augustine, M., Chen, K., Kuan, F.C., Marongiu, F., Evans, E.J., Jr., Moore, D.A., et al. (2023). Lung adenocarcinoma promotion by air pollutants. Nature 616, 159-167. 10.1038/s41586-023-05874-3.
145. Abby, E., Dentro, S.C., Hall, M.W.J., Fowler, J.C., Ong, S.H., Sood, R., Herms, A., Piedrafita, G., Abnizova, I., Siebel, C.W., et al. (2023). Notch1 mutations drive clonal expansion in normal esophageal epithelium but impair tumor growth. Nat Genet 55, 232-245. 10.1038/s41588-022-01280-z.
146. Wang, T., Pehrsson, E.C., Purushotham, D., Li, D., Zhuo, X., Zhang, B., Lawson, H.A., Province, M.A., Krapp, C., Lan, Y., et al. (2018). The NIEHS TaRGET II Consortium and environmental epigenomics. Nat Biotechnol 36, 225-227. 10.1038/nbt.4099.
147. Zhang, B.A., Miao, B., Fu, S., Coarfa, C., Kumar, R., Kuntala, P.K., Park, B., Grimm, S.L., Jangid, R., Colacino, J.A., et al. (2025). Comprehensive Transcriptomic and Epigenomic Insights into Environmental Toxicant Exposures: The TaRGET II Resource. bioRxiv. 10.1101/2025.07.28.667191.
148. Lim, A.I., McFadden, T., Link, V.M., Han, S.J., Karlsson, R.M., Stacy, A., Farley, T.K., Lima-Junior, D.S., Harrison, O.J., Desai, J.V., et al. (2021). Prenatal maternal infection promotes tissue-specific immunity and inflammation in offspring. Science 373. 10.1126/science.abf3002.
149. Naik, S., and Fuchs, E. (2022). Inflammatory memory and tissue adaptation in sickness and in health. Nature 607, 249-255. 10.1038/s41586-022-04919-3.
150. Stratton, M.R., Humphreys, L., Alexandrov, L.B., Balmain, A., Brennan, P., Campbell, P.J., and Phillips, D.H. (2025). Implementing Mutational Epidemiology on a Global Scale: Lessons from Mutographs. Cancer Discov 15, 22-27. 10.1158/2159-8290.Cd-24-1687.
151. Alexandrov, L.B., Kim, J., Haradhvala, N.J., Huang, M.N., Tian Ng, A.W., Wu, Y., Boot, A., Covington, K.R., Gordenin, D.A., Bergstrom, E.N., et al. (2020). The repertoire of mutational signatures in human cancer. Nature 578, 94-101. 10.1038/s41586-020-1943-3.
152. Díaz-Gay, M., Dos Santos, W., Moody, S., Kazachkova, M., Abbasi, A., Steele, C.D., Vangara, R., Senkin, S., Wang, J., Fitzgerald, S., et al. (2025). Geographic and age variations in mutational processes in colorectal cancer. Nature 643, 230-240. 10.1038/s41586-025-09025-8.
153. Coorens, T.H.H., Oh, J.W., Choi, Y.A., Lim, N.S., Zhao, B., Voshall, A., Abyzov, A., Antonacci-Fulton, L., Aparicio, S., Ardlie, K.G., et al. (2025). The Somatic Mosaicism across Human Tissues Network. Nature 643, 47-59. 10.1038/s41586-025-09096-7.
154. Gluckman, P.D., Hanson, M.A., Cooper, C., and Thornburg, K.L. (2008). Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359, 61-73. 10.1056/NEJMra0708473.
155. Feil, R., and Fraga, M.F. (2012). Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet 13, 97-109. 10.1038/nrg3142.
156. Walker, C.L., and Ho, S.M. (2012). Developmental reprogramming of cancer susceptibility. Nat Rev Cancer 12, 479-486. 10.1038/nrc3220.
157. Fitz-James, M.H., and Cavalli, G. (2022). Molecular mechanisms of transgenerational epigenetic inheritance. Nat Rev Genet 23, 325-341. 10.1038/s41576-021-00438-5.
158. Lesch, B.J., Tothova, Z., Morgan, E.A., Liao, Z., Bronson, R.T., Ebert, B.L., and Page, D.C. (2019). Intergenerational epigenetic inheritance of cancer susceptibility in mammals. Elife 8. 10.7554/eLife.39380.
159. Al Nabhani, Z., and Eberl, G. (2020). Imprinting of the immune system by the microbiota early in life. Mucosal Immunol 13, 183-189. 10.1038/s41385-020-0257-y.
160. Patti, M.E. (2013). Intergenerational programming of metabolic disease: evidence from human populations and experimental animal models. Cell Mol Life Sci 70, 1597-1608. 10.1007/s00018-013-1298-0.
161. Belkaid, Y., and Hand, T.W. (2014). Role of the microbiota in immunity and inflammation. Cell 157, 121-141. 10.1016/j.cell.2014.03.011.
162. Grivennikov, S.I., Greten, F.R., and Karin, M. (2010). Immunity, inflammation, and cancer. Cell 140, 883-899. 10.1016/j.cell.2010.01.025.
163. Sun, Y., Wang, Q., Zhang, Y., Geng, M., Wei, Y., Liu, Y., Liu, S., Petersen, R.B., Yue, J., Huang, K., and Zheng, L. (2020). Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p. J Hepatol 73, 603-615. 10.1016/j.jhep.2020.03.050.
164. Hilakivi-Clarke, L. (2014). Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters. Breast Cancer Res 16, 208. 10.1186/bcr3649.
165. Merlo, L.M., Pepper, J.W., Reid, B.J., and Maley, C.C. (2006). Cancer as an evolutionary and ecological process. Nat Rev Cancer 6, 924-935. 10.1038/nrc2013.
166. Laplane, L., and Maley, C.C. (2024). The evolutionary theory of cancer: challenges and potential solutions. Nat Rev Cancer 24, 718-733. 10.1038/s41568-024-00734-2.
167. Somarelli, J.A., Gardner, H., Cannataro, V.L., Gunady, E.F., Boddy, A.M., Johnson, N.A., Fisk, J.N., Gaffney, S.G., Chuang, J.H., Li, S., et al. (2020). Molecular Biology and Evolution of Cancer: From Discovery to Action. Mol Biol Evol 37, 320-326. 10.1093/molbev/msz242.
168. Greaves, M., and Maley, C.C. (2012). Clonal evolution in cancer. Nature 481, 306-313. 10.1038/nature10762.
169. Cannataro, V.L., Gaffney, S.G., and Townsend, J.P. (2018). Effect Sizes of Somatic Mutations in Cancer. J Natl Cancer Inst 110, 1171-1177. 10.1093/jnci/djy168.
170. Mandell, J.D., Cannataro, V.L., and Townsend, J.P. (2023). Estimation of Neutral Mutation Rates and Quantification of Somatic Variant Selection Using cancereffectsizeR. Cancer Res 83, 500-505. 10.1158/0008-5472.Can-22-1508.
171. Mauri, G., Patelli, G., Crisafulli, G., Siena, S., and Bardelli, A. (2025). Tumor "age" in early-onset colorectal cancer. Cell 188, 589-593. 10.1016/j.cell.2024.12.003.
172. Ashley, D.J. (1969). The two "hit" and multiple "hit" theories of carcinogenesis. Br J Cancer 23, 313-328. 10.1038/bjc.1969.41.
173. Lehallier, B., Gate, D., Schaum, N., Nanasi, T., Lee, S.E., Yousef, H., Moran Losada, P., Berdnik, D., Keller, A., Verghese, J., et al. (2019). Undulating changes in human plasma proteome profiles across the lifespan. Nat Med 25, 1843-1850. 10.1038/s41591-019-0673-2.
174. Oh, H.S., Rutledge, J., Nachun, D., Pálovics, R., Abiose, O., Moran-Losada, P., Channappa, D., Urey, D.Y., Kim, K., Sung, Y.J., et al. (2023). Organ aging signatures in the plasma proteome track health and disease. Nature 624, 164-172. 10.1038/s41586-023-06802-1.
175. Gail, M.H., Brinton, L.A., Byar, D.P., Corle, D.K., Green, S.B., Schairer, C., and Mulvihill, J.J. (1989). Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81, 1879-1886. 10.1093/jnci/81.24.1879.
176. Antoniou, A.C., Pharoah, P.D., McMullan, G., Day, N.E., Stratton, M.R., Peto, J., Ponder, B.J., and Easton, D.F. (2002). A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86, 76-83. 10.1038/sj.bjc.6600008.
177. Freedman, A.N., Slattery, M.L., Ballard-Barbash, R., Willis, G., Cann, B.J., Pee, D., Gail, M.H., and Pfeiffer, R.M. (2009). Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol 27, 686-693. 10.1200/jco.2008.17.4797.
178. Kastrinos, F., Kupfer, S.S., and Gupta, S. (2023). Colorectal Cancer Risk Assessment and Precision Approaches to Screening: Brave New World or Worlds Apart? Gastroenterology 164, 812-827. 10.1053/j.gastro.2023.02.021.
179. Pashayan, N., Antoniou, A.C., Ivanus, U., Esserman, L.J., Easton, D.F., French, D., Sroczynski, G., Hall, P., Cuzick, J., Evans, D.G., et al. (2020). Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol 17, 687-705. 10.1038/s41571-020-0388-9.
180. Louro, J., Posso, M., Hilton Boon, M., Román, M., Domingo, L., Castells, X., and Sala, M. (2019). A systematic review and quality assessment of individualised breast cancer risk prediction models. Br J Cancer 121, 76-85. 10.1038/s41416-019-0476-8.
181. Hull, M.A., Rees, C.J., Sharp, L., and Koo, S. (2020). A risk-stratified approach to colorectal cancer prevention and diagnosis. Nat Rev Gastroenterol Hepatol 17, 773-780. 10.1038/s41575-020-00368-3.
182. Gluckman, P.D., and Hanson, M.A. (2004). Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res 56, 311-317. 10.1203/01.Pdr.0000135998.08025.Fb.
183. Gluckman, P.D., and Hanson, M.A. (2004). Living with the past: evolution, development, and patterns of disease. Science 305, 1733-1736. 10.1126/science.1095292.
184. Rosner, B., and Colditz, G.A. (1996). Nurses' health study: log-incidence mathematical model of breast cancer incidence. J Natl Cancer Inst 88, 359-364. 10.1093/jnci/88.6.359.
185. Colditz, G.A., and Rosner, B. (2000). Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol 152, 950-964. 10.1093/aje/152.10.950.
186. Rice, M.S., Tworoger, S.S., Hankinson, S.E., Tamimi, R.M., Eliassen, A.H., Willett, W.C., Colditz, G., and Rosner, B. (2017). Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model. Breast Cancer Res Treat 166, 227-240. 10.1007/s10549-017-4391-5.
187. Baccarelli, A., Dolinoy, D.C., and Walker, C.L. (2023). A precision environmental health approach to prevention of human disease. Nat Commun 14, 2449. 10.1038/s41467-023-37626-2.
188. Kachuri, L., Graff, R.E., Smith-Byrne, K., Meyers, T.J., Rashkin, S.R., Ziv, E., Witte, J.S., and Johansson, M. (2020). Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction. Nat Commun 11, 6084. 10.1038/s41467-020-19600-4.
189. Yates, J., and Van Allen, E.M. (2025). New horizons at the interface of artificial intelligence and translational cancer research. Cancer Cell 43, 708-727. 10.1016/j.ccell.2025.03.018.
190. Jiang, S., Bennett, D.L., and Colditz, G.A. (2025). Validation of a Dynamic Risk Prediction Model Incorporating Prior Mammograms in a Diverse Population. JAMA Netw Open 8, e2512681. 10.1001/jamanetworkopen.2025.12681.
191. Jiang, S., Bennett, D.L., Rosner, B.A., Tamimi, R.M., and Colditz, G.A. (2024). Development and Validation of Dynamic 5-Year Breast Cancer Risk Model Using Repeated Mammograms. JCO Clin Cancer Inform 8, e2400200. 10.1200/cci-24-00200.
192. Schopf, C.M., Ramwala, O.A., Lowry, K.P., Hofvind, S., Marinovich, M.L., Houssami, N., Elmore, J.G., Dontchos, B.N., Lee, J.M., and Lee, C.I. (2024). Artificial Intelligence-Driven Mammography-Based Future Breast Cancer Risk Prediction: A Systematic Review. J Am Coll Radiol 21, 319-328. 10.1016/j.jacr.2023.10.018.
193. Shmatko, A., Jung, A.W., Gaurav, K., Brunak, S., Mortensen, L.H., Birney, E., Fitzgerald, T., and Gerstung, M. (2025). Learning the natural history of human disease with generative transformers. Nature 647, 248-256. 10.1038/s41586-025-09529-3.
194. Rockhill, B., Newman, B., and Weinberg, C. (1998). Use and misuse of population attributable fractions. Am J Public Health 88, 15-19. 10.2105/ajph.88.1.15.
195. Colditz, G.A., and Wei, E.K. (2012). Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. Annu Rev Public Health 33, 137-156. 10.1146/annurev-publhealth-031811-124627.
196. Stefan, N., Schick, F., and Häring, H.U. (2017). Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans. Cell Metab 26, 292-300. 10.1016/j.cmet.2017.07.008.
197. Hazelton, W.D., Ni, P., Harlass, M., Hahn, A.I., Tian, R., Zauber, A.G., Lansdorp-Vogelaar, I., and Cao, Y. (2024). Projected Trends of Obesity throughout the Life Course According to Sex, Race, and Birth Cohorts in the United States. medRxiv, 2024.2010.2015.24315456. 10.1101/2024.10.15.24315456.
198. Institute, N.C. Cancer Intervention and Surveillance Modeling Network. https://cisnet.cancer.gov/.
199. Caswell-Jin, J.L., Sun, L.P., Munoz, D., Lu, Y., Li, Y., Huang, H., Hampton, J.M., Song, J., Jayasekera, J., Schechter, C., et al. (2024). Analysis of Breast Cancer Mortality in the US-1975 to 2019. Jama 331, 233-241. 10.1001/jama.2023.25881.
200. Moolgavkar, S.H., Holford, T.R., Levy, D.T., Kong, C.Y., Foy, M., Clarke, L., Jeon, J., Hazelton, W.D., Meza, R., Schultz, F., et al. (2012). Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst 104, 541-548. 10.1093/jnci/djs136.
201. Edwards, B.K., Ward, E., Kohler, B.A., Eheman, C., Zauber, A.G., Anderson, R.N., Jemal, A., Schymura, M.J., Lansdorp-Vogelaar, I., Seeff, L.C., et al. (2010). Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116, 544-573. 10.1002/cncr.24760.
202. Vogelaar, I., van Ballegooijen, M., Schrag, D., Boer, R., Winawer, S.J., Habbema, J.D., and Zauber, A.G. (2006). How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer 107, 1624-1633. 10.1002/cncr.22115.
203. Hazelton, W.D., Jeon, J., Meza, R., and Moolgavkar, S.H. (2012). Chapter 8: The FHCRC lung cancer model. Risk Anal 32 Suppl 1, S99-s116. 10.1111/j.1539-6924.2011.01681.x.
204. Jeon, J., Meza, R., Hazelton, W.D., Renehan, A.G., and Luebeck, E.G. (2015). Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven analysis. Cancer Causes Control 26, 859-870. 10.1007/s10552-015-0559-7.
205. Curtius, K., Hazelton, W.D., Jeon, J., and Luebeck, E.G. (2015). A Multiscale Model Evaluates Screening for Neoplasia in Barrett's Esophagus. PLoS Comput Biol 11, e1004272. 10.1371/journal.pcbi.1004272.
206. Pepe, M.S., Etzioni, R., Feng, Z., Potter, J.D., Thompson, M.L., Thornquist, M., Winget, M., and Yasui, Y. (2001). Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93, 1054-1061. 10.1093/jnci/93.14.1054.
207. Srivastava, S., and Wagner, P.D. (2020). The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers. Cancer Epidemiol Biomarkers Prev 29, 2401-2410. 10.1158/1055-9965.Epi-20-0237.
